LRP1 and breast carcinoma: To study LRP-1 effects on multidrug resistant cells, two human breast carcinoma cells were used: parental MCF-7 cells sensitive to Dox called MCF-7S and MCF-7 cells resistant to Dox that were obtained by stepwise exposure of MCF-7S cells to increasing doses of Dox and called MCF-7R [47].